Quest Diagnostics (DGX) Reports In-Line Q2 EPS; Trims FY12 Revs Growth Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- US stock futures mixed as Apple slides, midterms loom
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Quest Diagnostics (NYSE: DGX) | Delayed: 250.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.81 | 52 Week High | $86.85 | |||
| Open | $250.81 | 52 Week Low | $59.66 | |||
| Day High | $250.81 | P/E | 47.23 | |||
| Day Low | $250.81 | EPS | $5.31 | |||
| Volume | 57 | |||||
